(CUPERTINO, Calif.)Drug developer Durect Corp. said Tuesday it applied for regulatory approval of Remoxy, designed to be an abuse-resistant form of oxycodone. The company submitted a new drug applica...READ MORE
(NEW YORK)Shares of drug developer Durect Corp. surged Thursday, after the company reported a smaller first-quarter loss on lower costs and greater research and development partnership reven...READ MORE
Among the earnings stories for Wednesday, May 7, from AP Financial News: CUPERTINO, Calif. (AP) _ Pharmaceutical company Durect Corp. said Wednesday its loss narrowed in the first ...READ MORE
(CUPERTINO, Calif.)
Durect Corp. said late Monday Endo Pharmaceuticals has decided to return the rights to implantable pain reliever Chronogesic, which it licensed from the company for the U.S. and C...READ MORE
(NEW YORK)Shares of pain drug developer Endo Pharmaceuticals Holdings Inc. are rising Thursday after Susquehanna Financial Group gave the company a positive outlook, citing revenue growth an...READ MORE